Browse studies, page 965

Page 965 of 1,287, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

In vitro activity of quinolones against S. pneumoniae, H. influenzae and M. catarrhalis in Saudi Arabia Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2005
Synergistic activity and immunomodulatory potential of levofloxacin and Synoeca-MP peptide against multi-resistant strains of Klebsiella pneumoniae Microbial pathogenesis, 2022
Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance Antimicrobial agents and chemotherapy, 2001
Synthesis and in vitro antibacterial activity of novel fluoroquinolone derivatives containing substituted piperidines Bioorganic & medicinal chemistry letters, 2010
Streptococcus pneumoniae in vitro development of resistance to amoxicillin/clavulanic acid, cefaclor, levofloxacin and azithromycin International journal of antimicrobial agents, 2004
Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin International journal of antimicrobial agents, 2002
New antibiotics for the therapy of respiratory tract infections Pneumologie (Stuttgart, Germany), 2006
Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae The Journal of antimicrobial chemotherapy, 2010
The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections American journal of therapeutics, 2009
Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016
Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria Bioorganic & medicinal chemistry letters, 2017
In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas Antimicrobial agents and chemotherapy, 2003
In vitro activity of tigecycline and comparators against gram-negative bacteria isolated from a tertiary hospital in Alexandria, Egypt Microbial drug resistance (Larchmont, N.Y.), 2011
Comparison of in vitro activities of tigecycline with other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in two university hospitals in Istanbul, Turkey Chemotherapy, 2009
Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells Chemotherapy, 2003
Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations BMC infectious diseases, 2015
Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria Revista da Associacao Medica Brasileira (1992), 1997
Evaluation of tigecycline activity in clinical isolates among Indian medical centers Indian journal of pathology & microbiology, 2010
Rhodococcus equi pericarditis in a patient living with HIV/AIDS. Journal of the International Association of Providers of AIDS Care, 2014
Tachyplesin Causes Membrane Instability That Kills Multidrug-Resistant Bacteria by Inhibiting the 3-Ketoacyl Carrier Protein Reductase FabG. Frontiers in microbiology, 2018
Activity of ceftolozane/tazobactam against Gram-negative isolates among different infections in Hong Kong: SMART 2017-2019 Journal of medical microbiology, 2022
Antimicrobial activity of ceftaroline combined with avibactam tested against bacterial organisms isolated from acute bacterial skin and skin structure infections in United States medical centers (2010-2012) Diagnostic microbiology and infectious disease, 2014
Occurrence and significance of fluoroquinolone-resistant and ESBL-producing Escherichia coli and Klebsiella pneumoniae complex of the rectal flora in Ghanaian patients undergoing prostate biopsy JAC-antimicrobial resistance, 2022
Synthesis and in vitro antibacterial activity of 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] pyridin-5(4H)-yl)fluoroquinolone derivatives Molecules (Basel, Switzerland), 2011
In vitro antimicrobial activity of moxifloxacin compared to other quinolones against recent clinical bacterial isolates from hospitalized and community-based cancer patients Diagnostic microbiology and infectious disease, 2003
Comparative in vitro activity of three fluoroquinolones against clinical isolates by E test Chemotherapy, 2003
Combination of Amphiphilic Cyclic Peptide [R4W4] and Levofloxacin against Multidrug-Resistant Bacteria Antibiotics (Basel, Switzerland), 2022
Antimicrobial resistance trends in community-acquired respiratory tract pathogens in the Western Pacific Region and South Africa: report from the SENTRY antimicrobial surveillance program, (1998-1999) including an in vitro evaluation of BMS284756 International journal of antimicrobial agents, 2002
Antimicrobial susceptibility among bacterial isolates from ICU and non-ICU setting and different age groups: results from the tigecycline evaluation and Surveillance trial in North America Journal of chemotherapy (Florence, Italy), 2009
Antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in Spain, 2004-2014 Journal of global antimicrobial resistance, 2016
Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness The Journal of antimicrobial chemotherapy, 2008
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents International journal of antimicrobial agents, 2005
Moxifloxacin: a comparison with other antimicrobial agents of in-vitro activity against Streptococcus pneumoniae The Journal of antimicrobial chemotherapy, 1998
In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. The Journal of antimicrobial chemotherapy, 2000
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Diagnostic microbiology and infectious disease, 2000
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae Antimicrobial agents and chemotherapy, 2001
In vitro antibacterial activity of gemifloxacin and comparator compounds against common respiratory pathogens The Journal of antimicrobial chemotherapy, 2000
In vitro activity of ABT-773, telithromycin and eight other antimicrobials against erythromycin-resistant Streptococcus pneumoniae respiratory isolates of children International journal of antimicrobial agents, 2001
Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999 MMWR. Morbidity and mortality weekly report, 2001
Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997) Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 1999
In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae Antimicrobial agents and chemotherapy, 2003
Clinical isolates of Streptococcus pneumoniae resistant to levofloxacin contain mutations in both gyrA and parC genes International journal of antimicrobial agents, 2001
Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000 International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2004
Clinical microbiology and infectious diseases - 11th European Congress. 1-4 April 2001, Istanbul, Turkey IDrugs : the investigational drugs journal, 2001
A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis Respirology (Carlton, Vic.), 2011
Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria Antimicrobial agents and chemotherapy, 2017
Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data Antimicrobial agents and chemotherapy, 2003
Evaluation of in vitro activity of ceftolozane/tazobactam and comparators against recent clinical bacterial isolates, and genomics of Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli isolates that demonstrated resistance to ceftolozane/tazobactam: data from Kuwait and Oman JAC-antimicrobial resistance, 2022
The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004 Revista portuguesa de pneumologia, 2006
Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999) Diagnostic microbiology and infectious disease, 2000
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa Antimicrobial agents and chemotherapy, 2009
Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4 Annals of clinical microbiology and antimicrobials, 2008
Vancomycin-tolerance among clinical isolates of Streptococcus pneumoniae in Mississippi during 1999-2001 The American journal of the medical sciences, 2005
In Vitro Evaluation of the Activity of β-Lactams, New Quinolones, and Other Antimicrobial Agents Against Streptococcus Pneumoniae Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 1996
Penicillin-resistant Streptococcus pneumoniae in Lebanon: the first nationwide study International journal of antimicrobial agents, 2006
In vitro activity of gemifloxacin against Streptococcus pneumoniae isolates in Germany Chemotherapy, 2001
In vitro susceptibility to antibiotics and the most common Streptococcus pneumoniae serotypes: a multicenter study Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2005
Third and fourth generation fluoroquinolones Revue medicale de Bruxelles, 2001
Comparative antimicrobial activity of levofloxacin and ciprofloxacin against Streptococcus pneumoniae The Journal of antimicrobial chemotherapy, 2003
In Vitro Antimicrobial Susceptibility Differences Between Carbapenem-Resistant KPC-2-Producing and NDM-1-Producing Klebsiella pneumoniae in a Teaching Hospital in Northeast China Microbial drug resistance (Larchmont, N.Y.), 2020
Comparative in vitro activities of four new fluoroquinolones against Streptococcus pneumoniae determined by Etest International journal of antimicrobial agents, 1998
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001) Diagnostic microbiology and infectious disease, 2003
In vitro activity of potential old and new drugs against multidrug-resistant gram-negatives Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2015
Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N'-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines European journal of medicinal chemistry, 2010
Antimicrobial susceptibility of extended-spectrum beta-lactamase producers and multidrug-resistant Acinetobacter baumannii throughout the United States and comparative in vitro activity of tigecycline, a new glycylcycline antimicrobial Diagnostic microbiology and infectious disease, 2007
In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008
In vitro evidence of the synergistic interaction of ceftopibrole and other antibiotics against multidrug-resistant Gram-negative isolates Diagnostic microbiology and infectious disease, 2019
In vitro activity of DC-159a, a new broad-spectrum fluoroquinolone, compared with that of other agents against drug-susceptible and -resistant pneumococci Antimicrobial agents and chemotherapy, 2008
In vitro activity of the new ketolide telithromycin and other antibiotics against Streptococcus pneumoniae in Belgium Acta clinica Belgica, 2001
Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019 BMC microbiology, 2021
In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates The Japanese journal of antibiotics, 1999
The Animal-foods-environment interface of Klebsiella pneumoniae in Germany: an observational study on pathogenicity, resistance development and the current situation Veterinary Research, 2021
Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns Therapeutics and Clinical Risk Management, 2014
Inhibiting PSMα-induced neutrophil necroptosis protects mice with MRSA pneumonia by blocking the agr system Cell Death and Disease, 2018
Isolation of Chlamydia abortus from a laboratory worker diagnosed with atypical pneumonia Irish Veterinary Journal, 2015
Pharmacokinetics of Intravenously Administered Levofloxacin in Men and Women Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 2005
Moxifloxacin modulates inflammation during murine pneumonia Respiratory Research, 2014
Emerging antibiotics for community-acquired pneumonia Expert Opinion on Emerging Drugs, 2019
Lung inflammatory pattern and antibiotic treatment in pneumonia Respiratory Research, 2015
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia European Respiratory Journal, 2009
2004 update of BTS pneumonia guidelines: what's new? Thorax, 2004
Concurrent Tuberculosis and Influenza, South Korea Emerging Infectious Diseases, 2013
Choice of antimicrobial therapy for Legionnella infection Nederlandsch tijdschrift voor geneeskunde, 2005
Impact of lipopolysaccharide-induced acute lung injury in aged mice Experimental Lung Research, 2023
A longitudinal molecular and cellular lung atlas of lethal SARS-CoV-2 infection in K18-hACE2 transgenic mice EBioMedicine, 2023
Ophiopogonin A alleviates acute lung inflammation via NF-κB/MAPK signaling pathway in a mouse model of Klebsiella pneumoniae Materials Express, 2023
Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia Science immunology, 2020
Gandan Oral Liquid Improves Exudative Pneumonia by Upregulating Bacteria Clearance via Regulating AQP5 and MUC5AC in Rats Evidence-Based Complementary and Alternative Medicine, 2022
Type III secretion system of Pseudomonas aeruginosa affects mucin gene expression via NF-κB and AKT signaling in human carcinoma epithelial cells and a pneumonia mouse model bioRxiv, 2018
Function of tissue-resident helper T cells in chronic lung sequelae following viral pneumonia Journal of Immunology, 2024
Experimental pneumonia with Pseudomonas aeruginosa in immunosuppressed guinea pigs as a model for biofilm-associated infection Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1995
Emergence and acquisition of fluoroquinolone-resistant gram-negative bacilli in the intestinal tracts of mice treated with fluoroquinolone antimicrobial agents Antimicrobial agents and chemotherapy, 2008
Molecular Characteristics of Klebsiella pneumoniae Isolated from Pigs Originating in Xinxiang, Henan Province Microbial drug resistance (Larchmont, N.Y.), 2026
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 6: exploration of aromatic substituents Bioorganic & medicinal chemistry, 2006
MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate Bioorganic & medicinal chemistry, 2007
In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia Antimicrobial agents and chemotherapy, 2001
Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae Antimicrobial agents and chemotherapy, 2006
Synthesis, antibacterial activity, and toxicity of 7-(isoindolin-5-yl)-4-oxoquinoline-3-carboxylic acids. Discovery of the novel des-F(6)-quinolone antibacterial agent garenoxacin (T-3811 or BMS-284756) Arzneimittel-Forschung, 2002
Protection and mechanism of Fagopyrum cymosum on lung injury in rats with Klebsiella pneumonia Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials, 2012
Simultaneous Semimechanistic Population Analyses of Levofloxacin in Plasma, Lung, and Prostate To Describe the Influence of Efflux Transporters on Drug Distribution following Intravenous and Intratracheal Administration Antimicrobial agents and chemotherapy, 2016